The biochemistry is real
Key advantages include: More significant weight loss in clinical trials Greater HbA1c reduction Fewer cravings and better appetite regulation Why Its More Effective: GLP-1 reduces appetite and improves glucose control
High blood cholesterol on its own has also been implicated in the loss of memory and mental function
The trial involved 443 participants who had inadequate glycemic control despite being on stable doses of oral antihyperglycemic medications
RELATED: 8 ways to save money on Ozempic How to save on Wegovy for weight loss Wegovy, DailyMed (2024) Ozempic, DailyMed (2025) Rybelsus, DailyMed (2024) Mounjaro, DailyMed (2025) Victoza, DailyMed (2024) Zepbound, DailyMed (2025) Saxenda, DailyMed (2024) Metformin, DailyMed (2020) RYBELSUS (semaglutide) savings and coverage tools for your patients, Novo Nordisk (2024) Chapter 6 Part drugs and formulary requirements, Medicare Prescription Drug Benefit Manual (2016) FDAs concerns with unapproved GLP-1 drugs used for weight loss, Food and Drug Administration (2024) FDA approves Zepbound (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity, Lilly (2024) Declaratory order: Resolution of shortages of tirzepatide injection products (Mounjaro and Zepbound), Food and Drug Administration (2024) FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, Food and Drug Administration (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
